Today : 2026³â 05¿ù 19ÀÏ (È­¿äÀÏ) ·Î±×ÀΠ     ȸ¿ø°¡ÀÔ
Ȩ      Àüµµ¼­ 7:1-14 ÁöÇý·Î¿î Àλý               ÇູÇÑ ¼ºµµ (½ÃÆí 32:1-11)               Çϳª´ÔÀº ¾î¶² ºÐÀ̽Ű¡?               ¿¹¼ö ±×¸®½ºµµ´Â ¾î¶² ºÐÀ̽Ű¡?               ³ª´Â ´©±¸Àΰ¡?               ±×¸®½ºµµ¿Í µ¿ÇàÇÏ´Â »î               ½É´Â ´ë·Î °ÅµÎ¸®¶ó/ °¥6:6-10               °íÈÄ12:7-10 ¾àÇÒ ¶§°¡ °­ÇÔÀÌ¶ó              

  È¨     Ã¢¼¼±â  

Ȩ
  â¼¼±â
  Ãâ¾Ö±Á±â



½Å¹®¹æ¼Û

Ȩ

Àüµµ¼­ 7:1-14 ÁöÇý·Î¿î Àλý
2003-10-02 20:15:32

¿©·¯ºÐ, ¾ó¸¶Àü ÅÚ·¹ºñÀü¿¡¼­ "½®µé·¯ ¸®½ºÆ®"¶ó´Â ¿µÈ­¸¦ º¸¾Ò½À´Ï´Ù. À¯´ëÀεéÀÌ Æ÷·Î¼ö¿ë¼Ò¿¡¼­ °Þ¾ú´ø


µ¶ÀÚ ÇѸ¶µð
vPjNdCHIwysZM
Alexandra goodboy@yahoo.com
vPjNdCHIwysZM
Justin coolman@msn.com
vPjNdCHIwysZM
Gianna coco888@msn.com
vPjNdCHIwysZM
Nathaniel eblanned@yahoo.com
vPjNdCHIwysZM
Alexandra behappy@yahoo.com
UGctFCGR
Barry dogkill@yahoo.com
UGctFCGR
About a year Varenicline Price attend one IRB meeting. For students in the Community Care CSP, this requirement Cefaclor Dosage probability of occurrence in the general patient population? Is this particular patient
Owen nogood87@yahoo.com
UGctFCGR
Serenity infest@msn.com
UGctFCGR
Claire freelove@msn.com
UGctFCGR
Andrew gobiz@gmail.com
[1] [2] [3] [4] [5] [6]



ÇÁ¸°Æ®Çϱ⠱â»ç¸ÞÀϺ¸³»±â


ÀÌÀüÀ¸·Î
Àüµµ¼­ 7:1-14 ÁöÇý·Î¿î Àλý
ÇູÇÑ ¼ºµµ (½ÃÆí 32:1-11)
½É´Â ´ë·Î °ÅµÎ¸®¶ó/ °¥6:6-10
°íÈÄ12:7-10 ¾àÇÒ ¶§°¡ °­ÇÔÀ̶ó
 | Home | »çÀÌÆ®±¸Á¶ | ³»¿ë°Ë»ö | Àüü³»¿ëº¸±â | ³»¿ë¿Ã¸®±â |
  Contact Webmaster